Zydus Cadila's sitagliptin and metformin hydrochloride extended-release tablets, a generic version of the diabetes drug Janumet XR, has been tentatively approved by the FDA. The drug will be released in three strengths -- 50 mg/500 mg, 50 mg/1,000 mg and 100 mg/1,000 mg.
FDA approves Zydus Cadila's generic anti-diabetes drug
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.